# TRV GP IV, LLC: Form 13F holdings

An institutional investment manager in Boston, MA. SEC CIK 1688325.

- Quarter ended: 2026-06-30
- Filed: 2026-08-10
- Reported value: $253.7m
- Positions: 2 (2 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1688325/000119312526340720/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [MAZE THERAPEUTICS, INC. (MAZE)](/companies/maze.md) | COM | $133.5m | 52.6% | 4,473,958 |  | Unchanged |
| [TANGO THERAPEUTICS, INC. (TNGX)](/companies/tngx.md) | COM | $120.2m | 47.4% | 6,374,574 |  | Unchanged |

Source: SEC EDGAR, Form 13F-HR, accession 0001193125-26-340720. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.